Adenosine A2A Receptor Is a Tumor Suppressor of NASH-Associated Hepatocellular Carcinoma

Researchers reported that anti-obesogenic and anti-inflammatory functions of adenosine A2A receptor significantly restrain HCC development. Adora2a deletion in mice triggered obesity, non-alcoholic steatohepatitis (NASH), and systemic inflammation.